Your browser doesn't support javascript.
loading
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Henriquez, Soledad; Zerbit, Jérémie; Bruel, Timothée; Ouedrani, Amani; Planas, Delphine; Deschamps, Paul; Staropoli, Isabelle; Hadjadj, Jérôme; Varet, Bruno; Ermak, Natalia; Bouscary, Didier; Willems, Lise; Fouquet, Guillemette; Decroocq, Justine; Franchi, Patricia; Deau-Fischer, Benedicte; Terrier, Benjamin; Tamburini, Jérôme; Chatenoud, Lucienne; Schwartz, Olivier; Vignon, Marguerite.
Afiliación
  • Henriquez S; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases.
  • Zerbit J; Department of Clinical Pharmacy, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Bruel T; Virus and Immunity Unit, Department of Virology, Institut Pasteur; Centre National de la Recherche Scientifique, Unite Mixte de Recherche (CNRS UMR) 3569, Paris, France.
  • Ouedrani A; Vaccine Research Institute, Créteil, France.
  • Planas D; Department of Biological Immunology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Necker-Enfants Malades, Paris, France.
  • Deschamps P; Université de Paris, CNRS UMR 8253 and INSERM UMR 1151, Institut Necker-Enfants Malades, Paris, France.
  • Staropoli I; Virus and Immunity Unit, Department of Virology, Institut Pasteur; Centre National de la Recherche Scientifique, Unite Mixte de Recherche (CNRS UMR) 3569, Paris, France.
  • Hadjadj J; Vaccine Research Institute, Créteil, France.
  • Varet B; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Ermak N; Virus and Immunity Unit, Department of Virology, Institut Pasteur; Centre National de la Recherche Scientifique, Unite Mixte de Recherche (CNRS UMR) 3569, Paris, France.
  • Bouscary D; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases.
  • Willems L; Department of Adult Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Necker-Enfants Malades, Paris, France.
  • Fouquet G; Department of Biological Immunology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Decroocq J; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Franchi P; Université de Paris, CNRS UMR 8104, INSERM U1016, Institut Cochin, Paris, France.
  • Deau-Fischer B; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Terrier B; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Tamburini J; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Chatenoud L; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Schwartz O; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôpital Cochin, Paris, France.
  • Vignon M; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases.
Blood ; 139(6): 942-946, 2022 02 10.
Article en En | MEDLINE | ID: mdl-34905598

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADP-Ribosil Ciclasa 1 / Antineoplásicos Inmunológicos / SARS-CoV-2 / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADP-Ribosil Ciclasa 1 / Antineoplásicos Inmunológicos / SARS-CoV-2 / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article